Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
19201
19202
19203
19204
19205
19206
19207
19208
19209
19210
19211
19212
19213
19214
19215
19216
19217
19218
19219
19220
19221
19222
19223
19224
19225
19226
19227
19228
19229
19230
19231
19232
19233
19234
19235
19236
19237
19238
19239
19240
19241
19242
19243
19244
19245
19246
19247
19248
19249
19250
19251
19252
19253
19254
19255
19256
19257
19258
19259
19260
19261
19262
19263
19264
19265
19266
19267
19268
19269
19270
19271
19272
19273
19274
19275
19276
19277
19278
19279
19280
19281
19282
19283
19284
19285
19286
19287
19288
19289
19290
19291
19292
19293
19294
19295
19296
19297
19298
19299
19300
19301
19302
19303
19304
19305
19306
19307
19308
19309
19310
19311
19312
19313
19314
19315
19316
19317
19318
19319
19320
19321
19322
19323
19324
19325
19326
19327
19328
19329
19330
19331
19332
19333
19334
19335
19336
19337
19338
19339
19340
19341
19342
19343
19344
19345
19346
19347
19348
19349
19350
19351
19352
19353
19354
19355
19356
19357
19358
19359
19360
19361
19362
19363
19364
19365
19366
19367
19368
19369
19370
19371
19372
19373
19374
19375
19376
19377
19378
19379
19380
19381
19382
19383
19384
19385
19386
19387
19388
19389
19390
19391
19392
19393
19394
19395
19396
19397
19398
19399
19400
| UnnamedSample_HQ_transcript/39251|m.11700 | UnnamedSample_HQ_transcript/39251 | Identity 0.747 too low. | 73725cac569388c24a408df2169ccb95 | 734 | Pfam | PF00856 | SET domain | 257 | 498 | 3.4E-14 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/34777|m.10668 | UnnamedSample_HQ_transcript/34777 | Identity 0.757 too low. | 73725cac569388c24a408df2169ccb95 | 734 | Pfam | PF13181 | Tetratricopeptide repeat | 588 | 608 | 0.12 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/34777|m.10668 | UnnamedSample_HQ_transcript/34777 | Identity 0.757 too low. | 73725cac569388c24a408df2169ccb95 | 734 | Pfam | PF00856 | SET domain | 257 | 498 | 3.4E-14 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/89570|m.21172 | UnnamedSample_HQ_transcript/89570 | Coverage 0.990 too low. | dfdf21003eebd07f484e383d916a666f | 325 | Pfam | PF00756 | Putative esterase | 67 | 318 | 3.9E-43 | T | 22-09-2020 | IPR000801 | Putative esterase |
| UnnamedSample_HQ_transcript/99019|m.22498 | UnnamedSample_HQ_transcript/99019 | Coverage 0.988 too low. | dfdf21003eebd07f484e383d916a666f | 325 | Pfam | PF00756 | Putative esterase | 67 | 318 | 3.9E-43 | T | 22-09-2020 | IPR000801 | Putative esterase |
| UnnamedSample_HQ_transcript/94228|m.21836 | UnnamedSample_HQ_transcript/94228 | Coverage 0.990 too low. | dfdf21003eebd07f484e383d916a666f | 325 | Pfam | PF00756 | Putative esterase | 67 | 318 | 3.9E-43 | T | 22-09-2020 | IPR000801 | Putative esterase |
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF13927 | Immunoglobulin domain | 56 | 116 | 1.4E-12 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF13927 | Immunoglobulin domain | 250 | 320 | 3.1E-13 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF13927 | Immunoglobulin domain | 431 | 503 | 8.5E-16 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF00041 | Fibronectin type III domain | 622 | 699 | 2.9E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF00041 | Fibronectin type III domain | 820 | 903 | 1.2E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF07679 | Immunoglobulin I-set domain | 338 | 426 | 9.0E-17 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/20357|m.6964 | UnnamedSample_HQ_transcript/20357 | Coverage 0.964 too low. | 7b16a4b103ccdfe74f103f426ba6c98b | 1068 | Pfam | PF07679 | Immunoglobulin I-set domain | 531 | 610 | 4.5E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/124279|m.25089 | UnnamedSample_HQ_transcript/124279 | Coverage 0.972 too low. | d712f086308c290ee79f38928a09362e | 106 | Pfam | PF00261 | Tropomyosin | 2 | 92 | 1.0E-33 | T | 22-09-2020 | IPR000533 | Tropomyosin |
| UnnamedSample_HQ_transcript/91998|m.21539 | UnnamedSample_HQ_transcript/91998 | Unmapped. | 26c38cd76c3a92b4efcd7f4945f5cc50 | 375 | Pfam | PF13087 | AAA domain | 135 | 306 | 9.9E-25 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/55479|m.15129 | UnnamedSample_HQ_transcript/55479 | Identity 0.602 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/55479|m.15129 | UnnamedSample_HQ_transcript/55479 | Identity 0.602 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/71325|m.18179 | UnnamedSample_HQ_transcript/71325 | Identity 0.582 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/71325|m.18179 | UnnamedSample_HQ_transcript/71325 | Identity 0.582 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/45543|m.13045 | UnnamedSample_HQ_transcript/45543 | Identity 0.647 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/45543|m.13045 | UnnamedSample_HQ_transcript/45543 | Identity 0.647 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/48056|m.13590 | UnnamedSample_HQ_transcript/48056 | Identity 0.637 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/48056|m.13590 | UnnamedSample_HQ_transcript/48056 | Identity 0.637 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/48202|m.13624 | UnnamedSample_HQ_transcript/48202 | Identity 0.679 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/48202|m.13624 | UnnamedSample_HQ_transcript/48202 | Identity 0.679 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/49088|m.13827 | UnnamedSample_HQ_transcript/49088 | Coverage 0.560 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/49088|m.13827 | UnnamedSample_HQ_transcript/49088 | Coverage 0.560 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/50447|m.14116 | UnnamedSample_HQ_transcript/50447 | Identity 0.669 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/50447|m.14116 | UnnamedSample_HQ_transcript/50447 | Identity 0.669 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/52439|m.14534 | UnnamedSample_HQ_transcript/52439 | Identity 0.616 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/52439|m.14534 | UnnamedSample_HQ_transcript/52439 | Identity 0.616 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/45045|m.12921 | UnnamedSample_HQ_transcript/45045 | Identity 0.648 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF13639 | Ring finger domain | 239 | 282 | 2.7E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/45045|m.12921 | UnnamedSample_HQ_transcript/45045 | Identity 0.648 too low. | 759ceca9a3679c1171c3f8bbed2ae3cf | 431 | Pfam | PF02225 | PA domain | 65 | 154 | 2.1E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/10514|m.3990 | UnnamedSample_HQ_transcript/10514 | Coverage 0.721 too low. | 50476ee181356c0301e36bdbe098a9b8 | 220 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 93 | 152 | 9.6E-13 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/101382|m.22797 | UnnamedSample_HQ_transcript/101382 | Coverage 0.955 too low. | 246b33311f2bf1e6ba601ea5d7bff182 | 334 | Pfam | PF07717 | Oligonucleotide/oligosaccharide-binding (OB)-fold | 240 | 317 | 5.3E-17 | T | 22-09-2020 | IPR011709 | Domain of unknown function DUF1605 |
| UnnamedSample_HQ_transcript/101382|m.22797 | UnnamedSample_HQ_transcript/101382 | Coverage 0.955 too low. | 246b33311f2bf1e6ba601ea5d7bff182 | 334 | Pfam | PF04408 | Helicase associated domain (HA2) | 94 | 192 | 1.3E-20 | T | 22-09-2020 | IPR007502 | Helicase-associated domain |
| UnnamedSample_HQ_transcript/107052|m.23471 | UnnamedSample_HQ_transcript/107052 | Coverage 0.961 too low. | 1af0f36ef03505643c986e4e19991078 | 121 | Pfam | PF01187 | Macrophage migration inhibitory factor (MIF) | 2 | 114 | 5.8E-37 | T | 22-09-2020 | IPR001398 | Macrophage migration inhibitory factor |
| UnnamedSample_HQ_transcript/92831|m.21638 | UnnamedSample_HQ_transcript/92831 | Coverage 0.948 too low. | c006efd0a4a9daaa739b4d07c5aa99d5 | 231 | Pfam | PF04387 | Protein tyrosine phosphatase-like protein, PTPLA | 63 | 220 | 5.1E-40 | T | 22-09-2020 | IPR007482 | Protein-tyrosine phosphatase-like, PTPLA |
| UnnamedSample_HQ_transcript/106656|m.23410 | UnnamedSample_HQ_transcript/106656 | Coverage 0.636 too low. | c006efd0a4a9daaa739b4d07c5aa99d5 | 231 | Pfam | PF04387 | Protein tyrosine phosphatase-like protein, PTPLA | 63 | 220 | 5.1E-40 | T | 22-09-2020 | IPR007482 | Protein-tyrosine phosphatase-like, PTPLA |
| UnnamedSample_HQ_transcript/112568|m.24146 | UnnamedSample_HQ_transcript/112568 | Coverage 0.585 too low. | c006efd0a4a9daaa739b4d07c5aa99d5 | 231 | Pfam | PF04387 | Protein tyrosine phosphatase-like protein, PTPLA | 63 | 220 | 5.1E-40 | T | 22-09-2020 | IPR007482 | Protein-tyrosine phosphatase-like, PTPLA |
| UnnamedSample_HQ_transcript/107808|m.23557 | UnnamedSample_HQ_transcript/107808 | Coverage 0.634 too low. | c006efd0a4a9daaa739b4d07c5aa99d5 | 231 | Pfam | PF04387 | Protein tyrosine phosphatase-like protein, PTPLA | 63 | 220 | 5.1E-40 | T | 22-09-2020 | IPR007482 | Protein-tyrosine phosphatase-like, PTPLA |
| UnnamedSample_HQ_transcript/109634|m.23788 | UnnamedSample_HQ_transcript/109634 | Coverage 0.617 too low. | c006efd0a4a9daaa739b4d07c5aa99d5 | 231 | Pfam | PF04387 | Protein tyrosine phosphatase-like protein, PTPLA | 63 | 220 | 5.1E-40 | T | 22-09-2020 | IPR007482 | Protein-tyrosine phosphatase-like, PTPLA |
| UnnamedSample_HQ_transcript/15594|m.5583 | UnnamedSample_HQ_transcript/15594 | Identity 0.904 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF00017 | SH2 domain | 484 | 562 | 1.3E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/15594|m.5583 | UnnamedSample_HQ_transcript/15594 | Identity 0.904 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF01017 | STAT protein, all-alpha domain | 31 | 197 | 2.4E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/15594|m.5583 | UnnamedSample_HQ_transcript/15594 | Identity 0.904 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF02864 | STAT protein, DNA binding domain | 232 | 364 | 1.7E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/17683|m.6216 | UnnamedSample_HQ_transcript/17683 | Identity 0.901 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF00017 | SH2 domain | 484 | 562 | 1.3E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/17683|m.6216 | UnnamedSample_HQ_transcript/17683 | Identity 0.901 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF01017 | STAT protein, all-alpha domain | 31 | 197 | 2.4E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/17683|m.6216 | UnnamedSample_HQ_transcript/17683 | Identity 0.901 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF02864 | STAT protein, DNA binding domain | 232 | 364 | 1.7E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/42031|m.12265 | UnnamedSample_HQ_transcript/42031 | Identity 0.931 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF00017 | SH2 domain | 484 | 562 | 1.3E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/42031|m.12265 | UnnamedSample_HQ_transcript/42031 | Identity 0.931 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF01017 | STAT protein, all-alpha domain | 31 | 197 | 2.4E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/42031|m.12265 | UnnamedSample_HQ_transcript/42031 | Identity 0.931 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF02864 | STAT protein, DNA binding domain | 232 | 364 | 1.7E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/19613|m.6765 | UnnamedSample_HQ_transcript/19613 | Identity 0.898 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF00017 | SH2 domain | 484 | 562 | 1.3E-9 | T | 22-09-2020 | IPR000980 | SH2 domain |
| UnnamedSample_HQ_transcript/19613|m.6765 | UnnamedSample_HQ_transcript/19613 | Identity 0.898 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF01017 | STAT protein, all-alpha domain | 31 | 197 | 2.4E-28 | T | 22-09-2020 | IPR013800 | STAT transcription factor, all-alpha domain |
| UnnamedSample_HQ_transcript/19613|m.6765 | UnnamedSample_HQ_transcript/19613 | Identity 0.898 too low. | 9cd2515d4ebc88ee2b756d8d2ce826c2 | 672 | Pfam | PF02864 | STAT protein, DNA binding domain | 232 | 364 | 1.7E-46 | T | 22-09-2020 | IPR013801 | STAT transcription factor, DNA-binding |
| UnnamedSample_HQ_transcript/18929|m.6559 | UnnamedSample_HQ_transcript/18929 | Coverage 0.610 too low. | 2787293ae5e25af7e6a860b8a86e9b3f | 615 | Pfam | PF00651 | BTB/POZ domain | 61 | 160 | 2.9E-25 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18929|m.6559 | UnnamedSample_HQ_transcript/18929 | Coverage 0.610 too low. | 2787293ae5e25af7e6a860b8a86e9b3f | 615 | Pfam | PF05225 | helix-turn-helix, Psq domain | 397 | 430 | 1.7E-6 | T | 22-09-2020 | IPR007889 | DNA binding HTH domain, Psq-type |
| UnnamedSample_HQ_transcript/99618|m.22577 | UnnamedSample_HQ_transcript/99618 | Unmapped. | dcac24c4573535898ee8ebcc49a5ea02 | 235 | Pfam | PF00118 | TCP-1/cpn60 chaperonin family | 7 | 211 | 2.6E-46 | T | 22-09-2020 | IPR002423 | Chaperonin Cpn60/TCP-1 family |
| UnnamedSample_HQ_transcript/14781|m.5348 | UnnamedSample_HQ_transcript/14781 | Coverage 0.860 too low. | 63689a7f49baeefc4a955f46cce7b9db | 898 | Pfam | PF07690 | Major Facilitator Superfamily | 97 | 280 | 3.6E-23 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/55318|m.15092 | UnnamedSample_HQ_transcript/55318 | Coverage 0.985 too low. | 7ecb43ce4db9ebc326ad8f2f8ceb56a9 | 416 | Pfam | PF00625 | Guanylate kinase | 79 | 258 | 4.2E-45 | T | 22-09-2020 | IPR008145 | Guanylate kinase/L-type calcium channel beta subunit |
| UnnamedSample_HQ_transcript/9770|m.3755 | UnnamedSample_HQ_transcript/9770 | Coverage 0.417 too low. | 537d503a870917ade0fec3a38aa18fb8 | 1217 | Pfam | PF00439 | Bromodomain | 353 | 433 | 5.1E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/6864|m.2816 | UnnamedSample_HQ_transcript/6864 | Coverage 0.753 too low. | 3e0fcb08ddacdfd2d580a9ead2d9b69a | 1029 | Pfam | PF02174 | PTB domain (IRS-1 type) | 17 | 79 | 3.3E-5 | T | 22-09-2020 | IPR002404 | IRS-type PTB domain |
| UnnamedSample_HQ_transcript/6864|m.2816 | UnnamedSample_HQ_transcript/6864 | Coverage 0.753 too low. | 3e0fcb08ddacdfd2d580a9ead2d9b69a | 1029 | Pfam | PF09141 | Talin, middle domain | 184 | 337 | 1.5E-41 | T | 22-09-2020 | IPR015224 | Talin, central |
| UnnamedSample_HQ_transcript/6864|m.2816 | UnnamedSample_HQ_transcript/6864 | Coverage 0.753 too low. | 3e0fcb08ddacdfd2d580a9ead2d9b69a | 1029 | Pfam | PF01608 | I/LWEQ domain | 947 | 1016 | 6.8E-26 | T | 22-09-2020 | IPR002558 | I/LWEQ domain |
| UnnamedSample_HQ_transcript/31647|m.9863 | UnnamedSample_HQ_transcript/31647 | Coverage 0.081 too low. | c60951a142ce9147120e911b42340687 | 394 | Pfam | PF11232 | Mediator complex subunit 25 PTOV activation and synapsin 2 | 33 | 181 | 5.3E-54 | T | 22-09-2020 | IPR021394 | Mediator complex, subunit Med25, PTOV domain |
| UnnamedSample_HQ_transcript/3667|m.1674 | UnnamedSample_HQ_transcript/3667 | Unmapped. | 1af5c42e5544dcc237371bc92d14eb8d | 1483 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1117 | 1442 | 2.0E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/3667|m.1674 | UnnamedSample_HQ_transcript/3667 | Unmapped. | 1af5c42e5544dcc237371bc92d14eb8d | 1483 | Pfam | PF00910 | RNA helicase | 55 | 163 | 5.3E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/3806|m.1737 | UnnamedSample_HQ_transcript/3806 | Unmapped. | 1af5c42e5544dcc237371bc92d14eb8d | 1483 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 1117 | 1442 | 2.0E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/3806|m.1737 | UnnamedSample_HQ_transcript/3806 | Unmapped. | 1af5c42e5544dcc237371bc92d14eb8d | 1483 | Pfam | PF00910 | RNA helicase | 55 | 163 | 5.3E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/2328|m.1180 | UnnamedSample_HQ_transcript/2328 | Unmapped. | 90caa327c201ce4e237f913a0dd36f36 | 963 | Pfam | PF13087 | AAA domain | 796 | 963 | 4.9E-22 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/2328|m.1180 | UnnamedSample_HQ_transcript/2328 | Unmapped. | 90caa327c201ce4e237f913a0dd36f36 | 963 | Pfam | PF13086 | AAA domain | 613 | 683 | 4.2E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/13322|m.4893 | UnnamedSample_HQ_transcript/13322 | Coverage 0.688 too low. | c562edd627ec880db38cb659dc50c2c5 | 1073 | Pfam | PF09128 | Regulator of G protein signalling-like domain | 532 | 719 | 6.8E-50 | T | 22-09-2020 | IPR015212 | Regulator of G protein signalling-like domain |
| UnnamedSample_HQ_transcript/13322|m.4893 | UnnamedSample_HQ_transcript/13322 | Coverage 0.688 too low. | c562edd627ec880db38cb659dc50c2c5 | 1073 | Pfam | PF00595 | PDZ domain | 62 | 133 | 7.4E-18 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/13322|m.4893 | UnnamedSample_HQ_transcript/13322 | Coverage 0.688 too low. | c562edd627ec880db38cb659dc50c2c5 | 1073 | Pfam | PF00130 | Phorbol esters/diacylglycerol binding domain (C1 domain) | 761 | 811 | 2.7E-11 | T | 22-09-2020 | IPR002219 | Protein kinase C-like, phorbol ester/diacylglycerol-binding domain |
| UnnamedSample_HQ_transcript/33145|m.10237 | UnnamedSample_HQ_transcript/33145 | Identity 0.463 too low. | 875d9753f34bc4ace80766963674fad0 | 786 | Pfam | PF00069 | Protein kinase domain | 36 | 291 | 3.7E-42 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/47724|m.13515 | UnnamedSample_HQ_transcript/47724 | Coverage 0.448 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 51 | 148 | 1.2E-10 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/47724|m.13515 | UnnamedSample_HQ_transcript/47724 | Coverage 0.448 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03723 | Hemocyanin, ig-like domain | 441 | 704 | 6.5E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/47724|m.13515 | UnnamedSample_HQ_transcript/47724 | Coverage 0.448 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF00372 | Hemocyanin, copper containing domain | 166 | 431 | 5.0E-56 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/42702|m.12417 | UnnamedSample_HQ_transcript/42702 | Coverage 0.494 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 51 | 148 | 1.2E-10 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/42702|m.12417 | UnnamedSample_HQ_transcript/42702 | Coverage 0.494 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03723 | Hemocyanin, ig-like domain | 441 | 704 | 6.5E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/42702|m.12417 | UnnamedSample_HQ_transcript/42702 | Coverage 0.494 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF00372 | Hemocyanin, copper containing domain | 166 | 431 | 5.0E-56 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/49486|m.13907 | UnnamedSample_HQ_transcript/49486 | Coverage 0.128 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 51 | 148 | 1.2E-10 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/49486|m.13907 | UnnamedSample_HQ_transcript/49486 | Coverage 0.128 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03723 | Hemocyanin, ig-like domain | 441 | 704 | 6.5E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/49486|m.13907 | UnnamedSample_HQ_transcript/49486 | Coverage 0.128 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF00372 | Hemocyanin, copper containing domain | 166 | 431 | 5.0E-56 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/47075|m.13384 | UnnamedSample_HQ_transcript/47075 | Coverage 0.457 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 51 | 148 | 1.2E-10 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/47075|m.13384 | UnnamedSample_HQ_transcript/47075 | Coverage 0.457 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF03723 | Hemocyanin, ig-like domain | 441 | 704 | 6.5E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/47075|m.13384 | UnnamedSample_HQ_transcript/47075 | Coverage 0.457 too low. | aee58da17a278057294ef0e4c884987b | 712 | Pfam | PF00372 | Hemocyanin, copper containing domain | 166 | 431 | 5.0E-56 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/7258|m.2942 | UnnamedSample_HQ_transcript/7258 | Coverage 0.195 too low. | 54bb246da752c694e868c850cf179216 | 938 | Pfam | PF07679 | Immunoglobulin I-set domain | 37 | 123 | 1.4E-20 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7258|m.2942 | UnnamedSample_HQ_transcript/7258 | Coverage 0.195 too low. | 54bb246da752c694e868c850cf179216 | 938 | Pfam | PF07679 | Immunoglobulin I-set domain | 127 | 218 | 2.0E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7258|m.2942 | UnnamedSample_HQ_transcript/7258 | Coverage 0.195 too low. | 54bb246da752c694e868c850cf179216 | 938 | Pfam | PF07679 | Immunoglobulin I-set domain | 232 | 315 | 9.7E-15 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/7258|m.2942 | UnnamedSample_HQ_transcript/7258 | Coverage 0.195 too low. | 54bb246da752c694e868c850cf179216 | 938 | Pfam | PF00041 | Fibronectin type III domain | 336 | 417 | 3.4E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/7258|m.2942 | UnnamedSample_HQ_transcript/7258 | Coverage 0.195 too low. | 54bb246da752c694e868c850cf179216 | 938 | Pfam | PF00041 | Fibronectin type III domain | 549 | 634 | 1.4E-14 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/33987|m.10459 | UnnamedSample_HQ_transcript/33987 | Coverage 0.714 too low. | 9dda0e1aad87cae4096994d13cecb7a5 | 546 | Pfam | PF01400 | Astacin (Peptidase family M12A) | 47 | 236 | 1.2E-49 | T | 22-09-2020 | IPR001506 | Peptidase M12A |
| UnnamedSample_HQ_transcript/70034|m.17938 | UnnamedSample_HQ_transcript/70034 | Coverage 0.743 too low. | 63670abc2b185ad7904ea9a29d7cd331 | 432 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/115399|m.24437 | UnnamedSample_HQ_transcript/115399 | Coverage 0.967 too low. | c3fefa97fa9f9c74f3519ce1a00a4d1a | 118 | Pfam | PF00135 | Carboxylesterase family | 11 | 104 | 1.7E-10 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 454 | 476 | 0.0076 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 230 | 252 | 0.0051 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 258 | 280 | 6.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 314 | 336 | 1.1E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 399 | 420 | 5.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/6655|m.2764 | UnnamedSample_HQ_transcript/6655 | Coverage 0.931 too low. | 33f24749e6314f9b565b9c30eb4a0ab8 | 623 | Pfam | PF00096 | Zinc finger, C2H2 type | 342 | 364 | 0.0012 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/118051|m.24682 | UnnamedSample_HQ_transcript/118051 | Identity 0.716 too low. | b50370ec548bfa5769094181526199fd | 235 | Pfam | PF00567 | Tudor domain | 73 | 154 | 5.8E-12 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/107261|m.23491 | UnnamedSample_HQ_transcript/107261 | Coverage 0.969 too low. | c3e661fba1c1643366ab5253c919b139 | 291 | Pfam | PF00651 | BTB/POZ domain | 19 | 117 | 4.7E-7 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/11859|m.4446 | UnnamedSample_HQ_transcript/11859 | Identity 0.803 too low. | d3191bbbc1ca541d442d9f1b7fe14177 | 325 | Pfam | PF00169 | PH domain | 1 | 94 | 2.4E-13 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/45040|m.12919 | UnnamedSample_HQ_transcript/45040 | Coverage 0.243 too low. | ba37db6a172fb92edb4d66d452f4e718 | 243 | Pfam | PF00412 | LIM domain | 98 | 154 | 9.9E-14 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/45040|m.12919 | UnnamedSample_HQ_transcript/45040 | Coverage 0.243 too low. | ba37db6a172fb92edb4d66d452f4e718 | 243 | Pfam | PF00412 | LIM domain | 34 | 91 | 7.8E-12 | T | 22-09-2020 | IPR001781 | Zinc finger, LIM-type |
| UnnamedSample_HQ_transcript/84453|m.20405 | UnnamedSample_HQ_transcript/84453 | Coverage 0.975 too low. | 19ed4b747bbf9aadb453d364e39c4cc3 | 396 | Pfam | PF00651 | BTB/POZ domain | 231 | 325 | 6.0E-19 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/90145|m.21275 | UnnamedSample_HQ_transcript/90145 | Identity 0.940 too low. | 19ed4b747bbf9aadb453d364e39c4cc3 | 396 | Pfam | PF00651 | BTB/POZ domain | 231 | 325 | 6.0E-19 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18812|m.6532 | UnnamedSample_HQ_transcript/18812 | Coverage 0.989 too low. | d81ecb6092e1cba65e4117b76f36c58f | 1041 | Pfam | PF00651 | BTB/POZ domain | 42 | 129 | 4.2E-10 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/18812|m.6532 | UnnamedSample_HQ_transcript/18812 | Coverage 0.989 too low. | d81ecb6092e1cba65e4117b76f36c58f | 1041 | Pfam | PF00651 | BTB/POZ domain | 328 | 435 | 1.4E-11 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/118579|m.24733 | UnnamedSample_HQ_transcript/118579 | Coverage 0.393 too low. | a8dbea3cb83a6fec508faebfb7ea71eb | 133 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 1.7E-37 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/80517|m.19803 | UnnamedSample_HQ_transcript/80517 | Coverage 0.534 too low. | 6d8d46a5fdb20bd793ec738041a6ef69 | 129 | Pfam | PF10601 | LITAF-like zinc ribbon domain | 58 | 125 | 9.5E-17 | T | 22-09-2020 | IPR006629 | LPS-induced tumour necrosis factor alpha factor |
| UnnamedSample_HQ_transcript/68690|m.17705 | UnnamedSample_HQ_transcript/68690 | Coverage 0.970 too low. | 5a3c2338818c555dddf1aa1378fff1b5 | 543 | Pfam | PF00135 | Carboxylesterase family | 7 | 533 | 5.5E-98 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/18888|m.6546 | UnnamedSample_HQ_transcript/18888 | Coverage 0.112 too low. | 928f3b029e3a75cc6397f2c66f1d3bea | 1056 | Pfam | PF08366 | LLGL2 | 280 | 373 | 5.1E-30 | T | 22-09-2020 | IPR013577 | Lethal giant larvae homologue 2 |
| UnnamedSample_HQ_transcript/18888|m.6546 | UnnamedSample_HQ_transcript/18888 | Coverage 0.112 too low. | 928f3b029e3a75cc6397f2c66f1d3bea | 1056 | Pfam | PF00400 | WD domain, G-beta repeat | 384 | 454 | 0.24 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/39027|m.11635 | UnnamedSample_HQ_transcript/39027 | Coverage 0.983 too low. | ed1f67148700776bd9a941d6a31c55b4 | 776 | Pfam | PF18264 | CXC domain | 590 | 621 | 2.5E-10 | T | 22-09-2020 | IPR041355 | Pre-SET CXC domain |
| UnnamedSample_HQ_transcript/39027|m.11635 | UnnamedSample_HQ_transcript/39027 | Coverage 0.983 too low. | ed1f67148700776bd9a941d6a31c55b4 | 776 | Pfam | PF00856 | SET domain | 653 | 756 | 1.8E-18 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/39027|m.11635 | UnnamedSample_HQ_transcript/39027 | Coverage 0.983 too low. | ed1f67148700776bd9a941d6a31c55b4 | 776 | Pfam | PF18118 | Polycomb repressive complex 2 tri-helical domain | 156 | 239 | 8.8E-22 | T | 22-09-2020 | IPR041343 | Polycomb repressive complex 2 subunit EZH1/EZH2, tri-helical domain |
| UnnamedSample_HQ_transcript/112960|m.24181 | UnnamedSample_HQ_transcript/112960 | Coverage 0.968 too low. | 62fe82a435082b55a2f0fed6fd3d2f35 | 240 | Pfam | PF00400 | WD domain, G-beta repeat | 74 | 112 | 6.0E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/112960|m.24181 | UnnamedSample_HQ_transcript/112960 | Coverage 0.968 too low. | 62fe82a435082b55a2f0fed6fd3d2f35 | 240 | Pfam | PF00400 | WD domain, G-beta repeat | 36 | 70 | 0.003 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/112960|m.24181 | UnnamedSample_HQ_transcript/112960 | Coverage 0.968 too low. | 62fe82a435082b55a2f0fed6fd3d2f35 | 240 | Pfam | PF00400 | WD domain, G-beta repeat | 116 | 154 | 3.8E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/112960|m.24181 | UnnamedSample_HQ_transcript/112960 | Coverage 0.968 too low. | 62fe82a435082b55a2f0fed6fd3d2f35 | 240 | Pfam | PF00400 | WD domain, G-beta repeat | 207 | 240 | 4.3E-4 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/112960|m.24181 | UnnamedSample_HQ_transcript/112960 | Coverage 0.968 too low. | 62fe82a435082b55a2f0fed6fd3d2f35 | 240 | Pfam | PF00400 | WD domain, G-beta repeat | 165 | 198 | 5.3E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/85954|m.20642 | UnnamedSample_HQ_transcript/85954 | Coverage 0.577 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/85954|m.20642 | UnnamedSample_HQ_transcript/85954 | Coverage 0.577 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/106540|m.23402 | UnnamedSample_HQ_transcript/106540 | Coverage 0.382 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/106540|m.23402 | UnnamedSample_HQ_transcript/106540 | Coverage 0.382 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/47991|m.13577 | UnnamedSample_HQ_transcript/47991 | Coverage 0.468 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/47991|m.13577 | UnnamedSample_HQ_transcript/47991 | Coverage 0.468 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/88499|m.21020 | UnnamedSample_HQ_transcript/88499 | Coverage 0.148 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/88499|m.21020 | UnnamedSample_HQ_transcript/88499 | Coverage 0.148 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/32269|m.10024 | UnnamedSample_HQ_transcript/32269 | Coverage 0.564 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/32269|m.10024 | UnnamedSample_HQ_transcript/32269 | Coverage 0.564 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/33599|m.10361 | UnnamedSample_HQ_transcript/33599 | Coverage 0.696 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/33599|m.10361 | UnnamedSample_HQ_transcript/33599 | Coverage 0.696 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/54923|m.15031 | UnnamedSample_HQ_transcript/54923 | Coverage 0.702 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/54923|m.15031 | UnnamedSample_HQ_transcript/54923 | Coverage 0.702 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/61240|m.16314 | UnnamedSample_HQ_transcript/61240 | Coverage 0.573 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/61240|m.16314 | UnnamedSample_HQ_transcript/61240 | Coverage 0.573 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/65980|m.17204 | UnnamedSample_HQ_transcript/65980 | Coverage 0.660 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/65980|m.17204 | UnnamedSample_HQ_transcript/65980 | Coverage 0.660 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/40305|m.11909 | UnnamedSample_HQ_transcript/40305 | Coverage 0.671 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/40305|m.11909 | UnnamedSample_HQ_transcript/40305 | Coverage 0.671 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/79458|m.19620 | UnnamedSample_HQ_transcript/79458 | Coverage 0.618 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/79458|m.19620 | UnnamedSample_HQ_transcript/79458 | Coverage 0.618 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/94735|m.21914 | UnnamedSample_HQ_transcript/94735 | Coverage 0.518 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/94735|m.21914 | UnnamedSample_HQ_transcript/94735 | Coverage 0.518 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/43994|m.12716 | UnnamedSample_HQ_transcript/43994 | Coverage 0.485 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/43994|m.12716 | UnnamedSample_HQ_transcript/43994 | Coverage 0.485 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/50238|m.14070 | UnnamedSample_HQ_transcript/50238 | Coverage 0.725 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/50238|m.14070 | UnnamedSample_HQ_transcript/50238 | Coverage 0.725 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/52417|m.14531 | UnnamedSample_HQ_transcript/52417 | Coverage 0.440 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/52417|m.14531 | UnnamedSample_HQ_transcript/52417 | Coverage 0.440 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/28821|m.9171 | UnnamedSample_HQ_transcript/28821 | Coverage 0.585 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/28821|m.9171 | UnnamedSample_HQ_transcript/28821 | Coverage 0.585 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/70713|m.18054 | UnnamedSample_HQ_transcript/70713 | Coverage 0.654 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/70713|m.18054 | UnnamedSample_HQ_transcript/70713 | Coverage 0.654 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/67646|m.17513 | UnnamedSample_HQ_transcript/67646 | Coverage 0.349 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/67646|m.17513 | UnnamedSample_HQ_transcript/67646 | Coverage 0.349 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/57335|m.15509 | UnnamedSample_HQ_transcript/57335 | Coverage 0.416 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/57335|m.15509 | UnnamedSample_HQ_transcript/57335 | Coverage 0.416 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/72167|m.18331 | UnnamedSample_HQ_transcript/72167 | Coverage 0.311 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/72167|m.18331 | UnnamedSample_HQ_transcript/72167 | Coverage 0.311 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/35546|m.10833 | UnnamedSample_HQ_transcript/35546 | Coverage 0.543 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/35546|m.10833 | UnnamedSample_HQ_transcript/35546 | Coverage 0.543 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/89819|m.21221 | UnnamedSample_HQ_transcript/89819 | Coverage 0.399 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/89819|m.21221 | UnnamedSample_HQ_transcript/89819 | Coverage 0.399 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/83683|m.20294 | UnnamedSample_HQ_transcript/83683 | Coverage 0.167 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/83683|m.20294 | UnnamedSample_HQ_transcript/83683 | Coverage 0.167 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/62645|m.16566 | UnnamedSample_HQ_transcript/62645 | Coverage 0.377 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/62645|m.16566 | UnnamedSample_HQ_transcript/62645 | Coverage 0.377 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/102272|m.22902 | UnnamedSample_HQ_transcript/102272 | Coverage 0.247 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/102272|m.22902 | UnnamedSample_HQ_transcript/102272 | Coverage 0.247 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/40851|m.12037 | UnnamedSample_HQ_transcript/40851 | Coverage 0.511 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/40851|m.12037 | UnnamedSample_HQ_transcript/40851 | Coverage 0.511 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/60616|m.16184 | UnnamedSample_HQ_transcript/60616 | Coverage 0.692 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/60616|m.16184 | UnnamedSample_HQ_transcript/60616 | Coverage 0.692 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/87602|m.20883 | UnnamedSample_HQ_transcript/87602 | Coverage 0.559 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/87602|m.20883 | UnnamedSample_HQ_transcript/87602 | Coverage 0.559 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/23670|m.7851 | UnnamedSample_HQ_transcript/23670 | Coverage 0.616 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/23670|m.7851 | UnnamedSample_HQ_transcript/23670 | Coverage 0.616 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/45032|m.12917 | UnnamedSample_HQ_transcript/45032 | Coverage 0.652 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/45032|m.12917 | UnnamedSample_HQ_transcript/45032 | Coverage 0.652 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/39140|m.11671 | UnnamedSample_HQ_transcript/39140 | Coverage 0.751 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/39140|m.11671 | UnnamedSample_HQ_transcript/39140 | Coverage 0.751 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/96312|m.22141 | UnnamedSample_HQ_transcript/96312 | Coverage 0.329 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/96312|m.22141 | UnnamedSample_HQ_transcript/96312 | Coverage 0.329 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/42984|m.12479 | UnnamedSample_HQ_transcript/42984 | Coverage 0.747 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/42984|m.12479 | UnnamedSample_HQ_transcript/42984 | Coverage 0.747 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/46104|m.13164 | UnnamedSample_HQ_transcript/46104 | Coverage 0.739 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/46104|m.13164 | UnnamedSample_HQ_transcript/46104 | Coverage 0.739 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/100059|m.22648 | UnnamedSample_HQ_transcript/100059 | Coverage 0.433 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/100059|m.22648 | UnnamedSample_HQ_transcript/100059 | Coverage 0.433 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/25979|m.8475 | UnnamedSample_HQ_transcript/25979 | Coverage 0.600 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 1 | 51 | 9.5E-13 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/25979|m.8475 | UnnamedSample_HQ_transcript/25979 | Coverage 0.600 too low. | e5f5b99b02ac390853042d7fdfcff6c3 | 168 | Pfam | PF01413 | C-terminal tandem repeated domain in type 4 procollagen | 56 | 166 | 5.9E-45 | T | 22-09-2020 | IPR001442 | Collagen IV, non-collagenous |
| UnnamedSample_HQ_transcript/74957|m.18826 | UnnamedSample_HQ_transcript/74957 | Coverage 0.153 too low. | aae43544777422e5d4aff57a72246e71 | 212 | Pfam | PF12248 | Farnesoic acid 0-methyl transferase | 99 | 185 | 7.5E-7 | T | 22-09-2020 | IPR022041 | Farnesoic acid O-methyl transferase |
| UnnamedSample_HQ_transcript/86054|m.20664 | UnnamedSample_HQ_transcript/86054 | Coverage 0.645 too low. | 7c756c0b4400501f3e54846babc07a54 | 308 | Pfam | PF03051 | Peptidase C1-like family | 1 | 302 | 2.0E-124 | T | 22-09-2020 | IPR004134 | Peptidase C1B, bleomycin hydrolase |
| UnnamedSample_HQ_transcript/20381|m.6971 | UnnamedSample_HQ_transcript/20381 | Coverage 0.983 too low. | bb9f4e6c5471d310228050a4780ba6e3 | 918 | Pfam | PF08389 | Exportin 1-like protein | 37 | 168 | 9.1E-6 | T | 22-09-2020 | IPR013598 | Exportin-1/Importin-beta-like |
| UnnamedSample_HQ_transcript/108927|m.23701 | UnnamedSample_HQ_transcript/108927 | Coverage 0.973 too low. | 09d008e9405c73eaeaf2ff9beb946c65 | 234 | Pfam | PF00183 | Hsp90 protein | 189 | 232 | 2.1E-11 | T | 22-09-2020 | IPR001404 | Heat shock protein Hsp90 family |
| UnnamedSample_HQ_transcript/108927|m.23701 | UnnamedSample_HQ_transcript/108927 | Coverage 0.973 too low. | 09d008e9405c73eaeaf2ff9beb946c65 | 234 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 33 | 186 | 7.7E-16 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/11172|m.4213 | UnnamedSample_HQ_transcript/11172 | Coverage 0.110 too low. | a92143625d93cc99f20fcb33f46e8257 | 524 | Pfam | PF01403 | Sema domain | 73 | 507 | 1.8E-125 | T | 22-09-2020 | IPR001627 | Sema domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
